Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nissay Capital is a Japanese venture capital firm specializing in seed to later-stage investments across various industries. It has invested in over 1,200 unlisted companies and achieved more than 220 IPOs since its founding in 1991. The firm operates as the corporate venture arm of Nippon Life Insurance Company and invests broadly, including technology and some healthcare/life science startups.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nissay Capital.